Percutaneous left ventricular assist devices for treatment of patients with cardiogenic shock

Current Opinion in Critical Care

Volumn 13, Issue 5, 2007, Pages 521-527

  Windecker, Stephan ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cardiogenic shock; Congestive heart failure; Intraaortic balloon pump; Left ventricular assist device

Indexed keywords

AORTA BALLOON; ASSISTED CIRCULATION; BLEEDING; CARDIOGENIC SHOCK; HEART INDEX; HEART LEFT VENTRICLE FAILURE; HEART OUTPUT; HEMODYNAMIC PARAMETERS; HUMAN; IMPLANT; KIDNEY FUNCTION; LACTATE BLOOD LEVEL; LIMB ISCHEMIA; MORTALITY; PATIENT CARE; PATIENT SELECTION; REVASCULARIZATION; REVIEW;

HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; INTRA-AORTIC BALLOON PUMPING; SHOCK, CARDIOGENIC; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34548396291     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e3282efd5bc     Document Type: Review

References (20)

1. Goldberg RJ, Samad NA, Yarzebski J, et al. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 1999; 340:1162-1168.
2. Rogers WJ, Canto JG, Lambrew CT, et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol 2000; 36:2056-2063.
3. Holmes DR Jr, Berger PB, Hochman JS, et al. Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation 1999; 100:2067-2073.
4. Hasdai D, Harrington RA, Hochman JS, et al. Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. J Am Coll Cardiol 2000; 36:685-692.
5. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock [see comments]. N Engl J Med 1999; 341:625-634.
6. Hochman JS, Sleeper LA, White HD, et al. One-year survival following early revascularization for cardiogenic shock. Jama 2001; 285:190-192.
7. Hochman JS, Buller CE, Sleeper LA, et al. Cardiogenic shock complicating acute myocardial infarction-etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 2000; 36:1063-1070.
8. Hollenberg SM, Kavinsky CJ, Parrillo JE. Cardiogenic shock. Ann Intern Med 1999; 131:47-59.
9. Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 2003; 107:2998-3002.
10. Laschinger JC, Grossi EA, Cunningham JN Jr, et al. Adjunctive left ventricular unloading during myocardial reperfusion plays a major role in minimizing myocardial infarct size. J Thorac Cardiovasc Surg 1985; 90:80-85.
11. Meyns B, Stolinski J, Leunens V, et al. Left ventricular support by cathetermounted axial flow pump reduces infarct size. J Am Coll Cardiol 2003; 41:1087-1095.
12. Barbone A, Holmes JW, Heerdt PM, et al. Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling. Circulation 2001; 104:670-675.
13. Tayara W, Starling RC, Yamani MH, et al. Improved survival after acute myocardial infarction complicated by cardiogenic shock with circulatory support and transplantation: comparing aggressive intervention with conservative treatment. J Heart Lung Transplant 2006; 25:504-509. This observational study supported an aggressive utilization of coronary revascularization procedures and cardiac assist devices including orthotopic heart transplantation in patients presenting with cardiogenic shock.
14. Thiele H, Lauer B, Hambrecht R, et al. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation 2001; 104:2917-2922.
15. Windecker S, Meier B. Percutaneous left ventricular assist devices [in German]. Kardiovaskuläre Medizin 2004; 7:26-32.
16. Henriques JP, Remmelink M, Baan J Jr, et al. Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. Am J Cardiol 2006; 97:990-992; Epub 2006 Feb 13.
17. Lemos PA, Cummins P, Lee CH, et al. Usefulness of percutaneous left ventricular assistance to support high-risk percutaneous coronary interventions. Am J Cardiol 2003; 91:479-481.
18. Valgimigli M, Steendijk P, Serruys P, et al. Use of Impella Recover LP 2.5 left ventricular assist device during high-risk percutaneous coronary interventions: clinical, haemodynamic and biochemical findings. EuroIntervention 2006; 2:91-100. This study described the hemodynamic effects of the Impella Recover system in humans using pressure-volume analysis.
19. Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2005; 26:1276-1283.
20. Burkhoff D, Cohen H, Brunckhorst C, O'Neill WW. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 2006; 152:469.e1-469.e8. This multicenter randomized trial compared the hemodynamic and clinical effects of the TandemHeart with the intraaortic balloon pump in patients with cardiogenic shock.